Human milk as a potential enteral source of erythropoietin

Pamela J. Kling, Tara M. Sullivan, Robin A. Roberts, Anthony F Philipps, Otakar Koldovský

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

In addition to its content of traditional nutrients, milk is a rich source of hormones and peptides, which survive digestion in the neonatal gastrointestinal tract secondary to lower proteolytic activity and increased protein permeability. Previous studies have shown accelerated erythropoiesis or elevated serum erythropoietin (Epo) levels in neonatal (suckling) animals after maternal phlebotomy or maternal hypoxia exposure. We sought to determine whether significant quantities of Epo are present in human milk and whether Epo remains intact under physiologic digestion conditions. Immunoreactive Epo concentrations were determined in 409 human milk samples obtained from mothers of term and premature infants. Samples collected between birth and postpartum d 134 were divided into 11 postpartum day groups. Mean milk-borne Epo concentrations were within the normal range for plasma Epo concentrations and rose with postpartum day (F10.398 = 5.82, p < 0.0001). No differences were observed between milk collected from mothers of premature versus term infants. Estimated weekly human milk-borne Epo intakes approximated the lower range of published parenteral therapeutic doses. In simulated digestion at physiologic pH levels of 3.2, 5.8, and 7.4, milk-borne Epo resisted degradation at 1 and 2 h, compared with baseline. Therefore, we conclude that human milk contains considerable amounts of Epo which resist degradation after exposure to gastric juices at physiologic pH levels. These results support continued investigation into the fate and developmental roles of Epo in human milk.

Original languageEnglish (US)
Pages (from-to)216-221
Number of pages6
JournalPediatric Research
Volume43
Issue number2
StatePublished - Feb 1998
Externally publishedYes

Fingerprint

Human Milk
Erythropoietin
Small Intestine
Milk
Postpartum Period
Digestion
Mothers
Suckling Animals
Newborn Animals
Maternal Exposure
Gastric Juice
Phlebotomy
Peptide Hormones
Erythropoiesis
Premature Infants
Gastrointestinal Tract
Permeability
Reference Values
Parturition
Food

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Kling, P. J., Sullivan, T. M., Roberts, R. A., Philipps, A. F., & Koldovský, O. (1998). Human milk as a potential enteral source of erythropoietin. Pediatric Research, 43(2), 216-221.

Human milk as a potential enteral source of erythropoietin. / Kling, Pamela J.; Sullivan, Tara M.; Roberts, Robin A.; Philipps, Anthony F; Koldovský, Otakar.

In: Pediatric Research, Vol. 43, No. 2, 02.1998, p. 216-221.

Research output: Contribution to journalArticle

Kling, PJ, Sullivan, TM, Roberts, RA, Philipps, AF & Koldovský, O 1998, 'Human milk as a potential enteral source of erythropoietin', Pediatric Research, vol. 43, no. 2, pp. 216-221.
Kling PJ, Sullivan TM, Roberts RA, Philipps AF, Koldovský O. Human milk as a potential enteral source of erythropoietin. Pediatric Research. 1998 Feb;43(2):216-221.
Kling, Pamela J. ; Sullivan, Tara M. ; Roberts, Robin A. ; Philipps, Anthony F ; Koldovský, Otakar. / Human milk as a potential enteral source of erythropoietin. In: Pediatric Research. 1998 ; Vol. 43, No. 2. pp. 216-221.
@article{b5945b5fb1694144838a21e5915b5cd0,
title = "Human milk as a potential enteral source of erythropoietin",
abstract = "In addition to its content of traditional nutrients, milk is a rich source of hormones and peptides, which survive digestion in the neonatal gastrointestinal tract secondary to lower proteolytic activity and increased protein permeability. Previous studies have shown accelerated erythropoiesis or elevated serum erythropoietin (Epo) levels in neonatal (suckling) animals after maternal phlebotomy or maternal hypoxia exposure. We sought to determine whether significant quantities of Epo are present in human milk and whether Epo remains intact under physiologic digestion conditions. Immunoreactive Epo concentrations were determined in 409 human milk samples obtained from mothers of term and premature infants. Samples collected between birth and postpartum d 134 were divided into 11 postpartum day groups. Mean milk-borne Epo concentrations were within the normal range for plasma Epo concentrations and rose with postpartum day (F10.398 = 5.82, p < 0.0001). No differences were observed between milk collected from mothers of premature versus term infants. Estimated weekly human milk-borne Epo intakes approximated the lower range of published parenteral therapeutic doses. In simulated digestion at physiologic pH levels of 3.2, 5.8, and 7.4, milk-borne Epo resisted degradation at 1 and 2 h, compared with baseline. Therefore, we conclude that human milk contains considerable amounts of Epo which resist degradation after exposure to gastric juices at physiologic pH levels. These results support continued investigation into the fate and developmental roles of Epo in human milk.",
author = "Kling, {Pamela J.} and Sullivan, {Tara M.} and Roberts, {Robin A.} and Philipps, {Anthony F} and Otakar Koldovsk{\'y}",
year = "1998",
month = "2",
language = "English (US)",
volume = "43",
pages = "216--221",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Human milk as a potential enteral source of erythropoietin

AU - Kling, Pamela J.

AU - Sullivan, Tara M.

AU - Roberts, Robin A.

AU - Philipps, Anthony F

AU - Koldovský, Otakar

PY - 1998/2

Y1 - 1998/2

N2 - In addition to its content of traditional nutrients, milk is a rich source of hormones and peptides, which survive digestion in the neonatal gastrointestinal tract secondary to lower proteolytic activity and increased protein permeability. Previous studies have shown accelerated erythropoiesis or elevated serum erythropoietin (Epo) levels in neonatal (suckling) animals after maternal phlebotomy or maternal hypoxia exposure. We sought to determine whether significant quantities of Epo are present in human milk and whether Epo remains intact under physiologic digestion conditions. Immunoreactive Epo concentrations were determined in 409 human milk samples obtained from mothers of term and premature infants. Samples collected between birth and postpartum d 134 were divided into 11 postpartum day groups. Mean milk-borne Epo concentrations were within the normal range for plasma Epo concentrations and rose with postpartum day (F10.398 = 5.82, p < 0.0001). No differences were observed between milk collected from mothers of premature versus term infants. Estimated weekly human milk-borne Epo intakes approximated the lower range of published parenteral therapeutic doses. In simulated digestion at physiologic pH levels of 3.2, 5.8, and 7.4, milk-borne Epo resisted degradation at 1 and 2 h, compared with baseline. Therefore, we conclude that human milk contains considerable amounts of Epo which resist degradation after exposure to gastric juices at physiologic pH levels. These results support continued investigation into the fate and developmental roles of Epo in human milk.

AB - In addition to its content of traditional nutrients, milk is a rich source of hormones and peptides, which survive digestion in the neonatal gastrointestinal tract secondary to lower proteolytic activity and increased protein permeability. Previous studies have shown accelerated erythropoiesis or elevated serum erythropoietin (Epo) levels in neonatal (suckling) animals after maternal phlebotomy or maternal hypoxia exposure. We sought to determine whether significant quantities of Epo are present in human milk and whether Epo remains intact under physiologic digestion conditions. Immunoreactive Epo concentrations were determined in 409 human milk samples obtained from mothers of term and premature infants. Samples collected between birth and postpartum d 134 were divided into 11 postpartum day groups. Mean milk-borne Epo concentrations were within the normal range for plasma Epo concentrations and rose with postpartum day (F10.398 = 5.82, p < 0.0001). No differences were observed between milk collected from mothers of premature versus term infants. Estimated weekly human milk-borne Epo intakes approximated the lower range of published parenteral therapeutic doses. In simulated digestion at physiologic pH levels of 3.2, 5.8, and 7.4, milk-borne Epo resisted degradation at 1 and 2 h, compared with baseline. Therefore, we conclude that human milk contains considerable amounts of Epo which resist degradation after exposure to gastric juices at physiologic pH levels. These results support continued investigation into the fate and developmental roles of Epo in human milk.

UR - http://www.scopus.com/inward/record.url?scp=0031908486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031908486&partnerID=8YFLogxK

M3 - Article

C2 - 9475287

AN - SCOPUS:0031908486

VL - 43

SP - 216

EP - 221

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 2

ER -